Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Carmell (CTCX)

Carmell Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CTCX
DateTimeSourceHeadlineSymbolCompany
11/04/202421:30GlobeNewswire Inc.Carmell Announces Successful Closing of $3.0 Million Private PlacementNASDAQ:CTCXCarmell Corporation
04/04/202413:30GlobeNewswire Inc.Carmell Announces $3.0 Million Private PlacementNASDAQ:CTCXCarmell Corporation
27/03/202413:15GlobeNewswire Inc.Carmell Announces Successful Closing of Axolotl Biologix Sale TransactionNASDAQ:CTCXCarmell Corporation
20/03/202420:39GlobeNewswire Inc.Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix SubsidiaryNASDAQ:CTCXCarmell Corporation
18/03/202419:16GlobeNewswire Inc.Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics FieldNASDAQ:CTCXCarmell Corporation
26/02/202413:30GlobeNewswire Inc.Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024NASDAQ:CTCXCarmell Corporation
05/01/202421:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTCXCarmell Corporation
19/12/202322:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
18/12/202322:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
18/12/202322:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
14/12/202302:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
14/12/202302:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
09/12/202302:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
09/12/202302:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
09/12/202302:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
09/12/202302:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
09/12/202302:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
09/12/202302:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
08/12/202321:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
08/12/202321:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
08/12/202321:21Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
01/12/202301:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
16/11/202313:30GlobeNewswire Inc.Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of DirectorsNASDAQ:CTCXCarmell Corporation
16/11/202302:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTCXCarmell Corporation
15/11/202321:56Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CTCXCarmell Corporation
25/10/202321:02Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CTCXCarmell Corporation
12/09/202317:35PR Newswire (US)Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative MedicineNASDAQ:CTCXCarmell Corporation
06/09/202321:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTCXCarmell Corporation
05/09/202323:03GlobeNewswire Inc.Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on AestheticsNASDAQ:CTCXCarmell Corporation
31/08/202302:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
 Showing the most relevant articles for your search:NASDAQ:CTCX